Publication | Closed Access
Melatonin MT1 and MT2 receptor expression in Parkinson's disease.
108
Citations
0
References
2010
Year
The results demonstrate a down-regulation of melatonin receptors in regions affected by PD, suggesting their possible involvement in the disease process. Future studies are needed to elucidate the role of melatonin and its receptors in the treatment/pathogenesis of PD.